中药临方制剂技术的发展现状及研究策略
|
摘要
临方制剂是指医生依据患者个体的辨证治疗需要和药物性能开具处方,提出临时的调配要求,再由负责调剂的人员按照相关工艺为患者加工成不同剂型的制剂,是个性化药学服务的重要内容。合理设计中药临方制剂的工艺路线、生产装备和质量控制方法,建立符合中药临方制剂特点的工艺研究策略与模式,对发展临方制剂具有重要的推动作用。该文全面综述了临方制剂的意义、政策、技术特点、工艺研究现状及存在的问题,提出了基于制剂原料物理特性的临方制剂技术、设备研发策略以及智能制造的研究方向,以期推动临方制剂技术规范化、标准化与智能化发展,促进临方制剂的传承与创新。
Temporary prescription preparation is the preparation processed into different dosage forms by relevant pharmacist according to the temporary preparation requirement and the personalized prescription made by the doctor in accordance with the syndrome differentiation and drug performance.It is an important part in personalized pharmaceutical services.Rational design of process route,production equipment and quality control method for the temporary prescription preparation,and establishment of technology research strategy and mode in accordance with the characteristics of traditional Chinese medicine temporary prescription preparations play an important role in promoting the development of the temporary prescription preparations.To promote the normalization,standardization and intelligent development of temporary prescription preparations,we would comprehensively summarize the significance,policy,technology characteristics,technology research status quo and existing problems in this paper,and put forward the research direction of temporary prescription preparation technology based on the physical properties of raw materials,equipment research strategy,and intelligent manufacturing technology.Thus it will push the inheritance and innovation of temporary prescription preparation.
Temporary prescription preparation is the preparation processed into different dosage forms by relevant pharmacist according to the temporary preparation requirement and the personalized prescription made by the doctor in accordance with the syndrome differentiation and drug performance.It is an important part in personalized pharmaceutical services.Rational design of process route,production equipment and quality control method for the temporary prescription preparation,and establishment of technology research strategy and mode in accordance with the characteristics of traditional Chinese medicine temporary prescription preparations play an important role in promoting the development of the temporary prescription preparations.To promote the normalization,standardization and intelligent development of temporary prescription preparations,we would comprehensively summarize the significance,policy,technology characteristics,technology research status quo and existing problems in this paper,and put forward the research direction of temporary prescription preparation technology based on the physical properties of raw materials,equipment research strategy,and intelligent manufacturing technology.Thus it will push the inheritance and innovation of temporary prescription preparation.
引文
[1]陈丽华,朱江,张吉菲,等.基层中医医院中药学工作的发展研究[J].中国医药学导报,2012,9(34):158.
[2]冯文杰,贾晓斌,刘丹.影响煎煮汤剂质量的多因素分析及规范化管理研究[J].中草药,2014,45(16):2422.
[3]邓丙戌.皮肤病外用中药的临方调配[C].北京:中华中医药学会皮肤科分会第六次学术年会、赵炳南学术思想研讨会、全国皮肤科中医外治高级研修班,2009:4.
[4]冯爽,李景春,谢芝丽,等.初探临方制剂对中药临床应用的影响[J].中国医院药学杂志,2014,34(21):1870.
[5]张丽青,李景春,冯爽.临方制剂中存在的问题与对策[J].中医药管理杂志,2014,22(1):72.
[6]万宏.医院中药房开展中药临方炮制的意义[J].中华中医药杂志,2017,32(7):2867.
[7]林雪芳.医院中药调配临方炮制的必要性[J].中国现代药物应用,2011,5(2):235.
[8]李清.中药临方炮制分析与探讨[J].河南中医,2014,34(4):587.
[9]陈宏志,何建成,洪芳.近20年辨证论治研究重点概述[J].中华中医药学刊,2013,31(4):778.
[10]薛飞飞,陈家旭.中医辨证论治体系的形成与发展[J].北京中医药大学学报,2006,29(10):658.
[11]朱文涛,卢双.浅谈中药院内制剂存在价值[J].中医药管理杂志,2009,17(4):347.
[12]黄德红,王兵娥.中医医院院内制剂的发展及对策[J].中医药管理杂志,2013,21(10):1085.
[13]钟赣生,李少华.《神农本草经》的药物成就[J].中华中医药杂志,2006(7):390.
[14]郭炜.雷丸古今临床应用概述[J].辽宁中医杂志,2014,41(9):1866.
[15]王鑫,刘剑云,张定堃,等.青黛饮片亲水性改性工艺的优选研究[J].中草药,2016,47(3):401.
[16]李范珠,李永吉.中药药剂学[M].北京:人民卫生出版社,2016:4.
[17]柳文红,王思农.斑秃中医药治疗研究进展[J].甘肃中医学院学报,2013,30(3):88.
[18]唐志芳,郑依玲,梅全喜.中药药学服务的特点、存在问题及对策[J].中国药师,2017,20(9):1588.
[19]李原,石新华,范彦博.开展中药临方炮制对发挥中医特色的意义[J].中国医院药学杂志,2012,32(6):465.
[20]何蔚,任麒,沈慧凤.固体制剂用新辅料的开发[J].中国医药工业杂志,2006(12):844.
[21]姚勤,王晶晶,郑巧玲,等.口服固体制剂精准分剂量在精准用药中的探索与实践[J].中国医院药学杂志,2018,38(5):562.
[22]张定堃,杨明,林俊芝,等.中药散剂的制法研究[J].中华中医药杂志,2014,29(1):21.
[23]李宁.传统散剂在临床中的应用[J].中医临床研究,2016,8(10):119.
[24]杨明,韩丽,杨胜,等.基于传统丸、散剂特点的中药粒子设计技术研究[J].中草药,2012,43(1):9.
[25]张臻,高天慧,傅超美,等.中药丸剂剂型理论与应用现状关键问题分析[J].中国中药杂志,2017,42(12):2408.
[26]苑冬敏.中药特色技术手工泛丸法在个体化用药服务中应用体会[J].辽宁中医药大学学报,2018,20(3):8.
[27]王霞.手工案匾泛制水丸制备经验总结[J].辽宁中医药大学学报,2017,19(9):135.
[28]冯怡.中药固体制剂技术理论与实践[M].北京:中国中医药出版社,2017:131.
[29]张茂,王锡品.我院开展水丸制剂的探讨[J].大家健康:学术版,2013,7(14):26.
[30]门乐,鲜洁晨,洪燕龙,等.4种辅料空白丸芯制备工艺的优选及差异性分析[J].中国实验方剂学杂志,2013,19(10):1.
[31]吴承云,郑清明,周亚莉,等.试论中药制剂规格标示的合理性及规范性[J].中国药事,2012,26(1):47.
[32]范碧亭.中药药剂学[M].上海:上海科学技术出版社,1997:392.
[33]罗超,罗越,陈麒同,等.颗粒剂制备方法的研究进展[J].甘肃科技,2014,30(21):140.
[34]王丽.中药颗粒剂制备工艺研究进展[J].内蒙古中医药,2018,37(4):109.
[35]徐忠瑞.基于中药汤剂的个体化复方颗粒的研究[D].南京:南京中医药大学,2016.
[36]刘慧民,刘玉明,陈向齐,等.中药外用制剂在皮肤疾病中的临床应用及研究进展[J].现代中药研究与实践,2014,28(4):70.
[37]阙慧卿,钱丽萍,林绥,等.外用制剂的药动学研究进展[J].药物评价研究,2012,35(5):378.
[38]郑智音,贾晓斌,舒娈,等.中药外用制剂皮肤过敏动物实验模型及评价指标研究探讨[J].中华中医药杂志,2011,26(12):2929.
[39]苟志林,曹大春,刘玉芬,等.中医医院积极开展中药临方炮制的思路与方法[J].光明中医,2016,31(3):431.
[40]杜若飞,冯怡,徐德生,等.湿法制粒中软材物性参数的表征方法研究[C].山西:2009全国中药创新与研究论坛,2009:85.
[41]Du Y,Zhao L J,Feng Y,et al.Compression behavior evaluation of directly compressible excipients[J].Adv Mater Res,2012,428/484:1672.
[42]高雅,洪燕龙,鲜洁晨,等.物性测试仪用于制剂软材特征物理性质的表征方法研究[J].药学学报,2012(8):1049.
[43]Gao Y,Hong Y,Xian J,et al.A protocol for the classification of wet mass in extrusion-spheronization[J].Eur J Pharm Biopharm,2013,85(3):996.
[44]L X H,Zhao L J,Ruan K P,et al.The application of factor analysis to evaluate deforming behaviors of directly compressed powders[J].Powder Technol,2013,247:47.
[45]王玲,鲜洁晨,洪燕龙,等.塑制法制备中药丸剂中丸条物理特性丸剂质量相关性研究[J].中国中药杂志,2012,37(9):1206.
[46]Wang S,Li J,Lin X,et al.Novel coprocessed excipients composed of lactose,HPMC,and PVPP for tableting and its application[J].Int J Pharm,2015,486(1/2):370.
[47]Li J,Lin X,Wu F,et al.Application of the central composite design to optimize the calcium carbonate-HPMC co-processed excipient prepared by co-spray drying[J].RSC Adv,2015,5(114):94105.
[48]Li J,Wu F,Lin X,et al.Novel application of hydroxypropyl methylcellulose to improving direct compaction properties of tablet fillers by co-spray drying[J].RSC Adv,2015,5(85):69289.
[49]Sun C C.A classification system for tableting behaviors of binary powder mixtures[J].Asian J Pharm Sci,2016,11(4):486.
[50]Li Z,Lin X,Shen L,et al.Composite particles based on particle engineering for direct compaction[J].Int J Pharm,2017,519(1/2):272.
[51]Li J,Zhao L,Lin X,et al.Co-spray drying with HPMC as a platform to improve direct compaction properties of various tablet fillers[J].AAPS Pharm Sci Tech,2017,18(8):3105.
[52]M L S,Li Z,Wu F,et al.A two-step approach for fluidized bed granulation in pharmaceutical processing:assessing different models for design and control[J].PLoS ONE,2017,12(6):e0180209.
[53]李雪,洪燕龙,鲜洁晨,等.基于转矩流变性的中药微丸润湿剂用量筛选研究[J].中国中药杂志,2017,42(17):3341.
[54]李雪,洪燕龙,杜若飞,等.挤出滚圆过程中挤出物表面粗糙度的表征方法[J].中国医药工业杂志,2017(1):63.
[55]李雪.基于挤出物表面粗糙度的中药微丸成型性假说验证研究[D].上海:上海中医药大学,2017.
[56]明良山,李哲,吴飞,等.基于表面自由能性质的物料压缩特性研究[J].药学学报,2017,52(7):1170.
[57]郑亚平.基于挤出物表面粗糙度的中药微丸成型基础研究[D].上海:上海中医药大学,2018.
[58]冯怡,洪燕龙,鲜洁晨,等.基于QbD理念的中药新药成型工艺研发模式的探讨[J].中国中药杂志,2014,39(17):3404.
[59]刘怡,冯怡,徐德生.中药制剂技术研究应关注提取物的物理性质[J].中成药,2007(10):1495.
[60]冯怡,杜若飞,洪燕龙,等.关于构建中药制剂工艺设计专家系统的思考[J].世界科学技术---中医药现代化,2013,15(1):25.
[61]姬杰玮.Fitzpatrick公司干法制粒机的动态观察与探讨[J].机电信息,2013(2):53.
[62]赵立杰,冯怡,徐德生,等.基于多元数据分析研究中药制剂原料吸湿性与其他物理特性的相关性[J].药学学报,2012,47(4):517.
[63]Michrafy A,Diarra H,Dodds J A,et al.Analysis of strain stress state in roller compaction process[J].Power Technol,2011,208(2):417.
[64]李洁,杜若飞,冯怡,等.中药浸膏粉物理性质与干法制粒工艺的相关性研究[J].中国中药杂志,2011,36(12):1606.
[65]杨秀娟,洪燕龙,阮克锋,等.基于制剂原料物理特性的止颤颗粒干法制粒处方与工艺优选[J].中国实验方剂学杂志,2013,19(4):27.
[66]李更青,吴飞,胡佳亮,等.基于制剂原料物理性质的抗甲方颗粒干法制粒工艺研究[J].中草药,2018,49(3):575.
[67]朱蕾,李姝琦,冯怡,等.物料物理性质与片剂成型性的相关性研究[J].中成药,2010,32(8):1402.
[68]杨明,伍振峰,王芳,等.中药制药实现绿色、智能制造的策略与建议[J].中国医药工业杂志,2016,47(9):1205.
[69]中国智慧制药2025”杭州宣言发布[J].天津中医药,2017,34(1):2.
[70]中国智慧制药2025”高峰论坛:发布“中国智慧制药2025”杭州宣言[J].中国中药杂志,2016,41(24):4468.
[71]杨明,伍振峰,王雅琪,等.中药制药装备技术升级的政策、现状与途径分析[J].中草药,2013,44(3):247.
[2]冯文杰,贾晓斌,刘丹.影响煎煮汤剂质量的多因素分析及规范化管理研究[J].中草药,2014,45(16):2422.
[3]邓丙戌.皮肤病外用中药的临方调配[C].北京:中华中医药学会皮肤科分会第六次学术年会、赵炳南学术思想研讨会、全国皮肤科中医外治高级研修班,2009:4.
[4]冯爽,李景春,谢芝丽,等.初探临方制剂对中药临床应用的影响[J].中国医院药学杂志,2014,34(21):1870.
[5]张丽青,李景春,冯爽.临方制剂中存在的问题与对策[J].中医药管理杂志,2014,22(1):72.
[6]万宏.医院中药房开展中药临方炮制的意义[J].中华中医药杂志,2017,32(7):2867.
[7]林雪芳.医院中药调配临方炮制的必要性[J].中国现代药物应用,2011,5(2):235.
[8]李清.中药临方炮制分析与探讨[J].河南中医,2014,34(4):587.
[9]陈宏志,何建成,洪芳.近20年辨证论治研究重点概述[J].中华中医药学刊,2013,31(4):778.
[10]薛飞飞,陈家旭.中医辨证论治体系的形成与发展[J].北京中医药大学学报,2006,29(10):658.
[11]朱文涛,卢双.浅谈中药院内制剂存在价值[J].中医药管理杂志,2009,17(4):347.
[12]黄德红,王兵娥.中医医院院内制剂的发展及对策[J].中医药管理杂志,2013,21(10):1085.
[13]钟赣生,李少华.《神农本草经》的药物成就[J].中华中医药杂志,2006(7):390.
[14]郭炜.雷丸古今临床应用概述[J].辽宁中医杂志,2014,41(9):1866.
[15]王鑫,刘剑云,张定堃,等.青黛饮片亲水性改性工艺的优选研究[J].中草药,2016,47(3):401.
[16]李范珠,李永吉.中药药剂学[M].北京:人民卫生出版社,2016:4.
[17]柳文红,王思农.斑秃中医药治疗研究进展[J].甘肃中医学院学报,2013,30(3):88.
[18]唐志芳,郑依玲,梅全喜.中药药学服务的特点、存在问题及对策[J].中国药师,2017,20(9):1588.
[19]李原,石新华,范彦博.开展中药临方炮制对发挥中医特色的意义[J].中国医院药学杂志,2012,32(6):465.
[20]何蔚,任麒,沈慧凤.固体制剂用新辅料的开发[J].中国医药工业杂志,2006(12):844.
[21]姚勤,王晶晶,郑巧玲,等.口服固体制剂精准分剂量在精准用药中的探索与实践[J].中国医院药学杂志,2018,38(5):562.
[22]张定堃,杨明,林俊芝,等.中药散剂的制法研究[J].中华中医药杂志,2014,29(1):21.
[23]李宁.传统散剂在临床中的应用[J].中医临床研究,2016,8(10):119.
[24]杨明,韩丽,杨胜,等.基于传统丸、散剂特点的中药粒子设计技术研究[J].中草药,2012,43(1):9.
[25]张臻,高天慧,傅超美,等.中药丸剂剂型理论与应用现状关键问题分析[J].中国中药杂志,2017,42(12):2408.
[26]苑冬敏.中药特色技术手工泛丸法在个体化用药服务中应用体会[J].辽宁中医药大学学报,2018,20(3):8.
[27]王霞.手工案匾泛制水丸制备经验总结[J].辽宁中医药大学学报,2017,19(9):135.
[28]冯怡.中药固体制剂技术理论与实践[M].北京:中国中医药出版社,2017:131.
[29]张茂,王锡品.我院开展水丸制剂的探讨[J].大家健康:学术版,2013,7(14):26.
[30]门乐,鲜洁晨,洪燕龙,等.4种辅料空白丸芯制备工艺的优选及差异性分析[J].中国实验方剂学杂志,2013,19(10):1.
[31]吴承云,郑清明,周亚莉,等.试论中药制剂规格标示的合理性及规范性[J].中国药事,2012,26(1):47.
[32]范碧亭.中药药剂学[M].上海:上海科学技术出版社,1997:392.
[33]罗超,罗越,陈麒同,等.颗粒剂制备方法的研究进展[J].甘肃科技,2014,30(21):140.
[34]王丽.中药颗粒剂制备工艺研究进展[J].内蒙古中医药,2018,37(4):109.
[35]徐忠瑞.基于中药汤剂的个体化复方颗粒的研究[D].南京:南京中医药大学,2016.
[36]刘慧民,刘玉明,陈向齐,等.中药外用制剂在皮肤疾病中的临床应用及研究进展[J].现代中药研究与实践,2014,28(4):70.
[37]阙慧卿,钱丽萍,林绥,等.外用制剂的药动学研究进展[J].药物评价研究,2012,35(5):378.
[38]郑智音,贾晓斌,舒娈,等.中药外用制剂皮肤过敏动物实验模型及评价指标研究探讨[J].中华中医药杂志,2011,26(12):2929.
[39]苟志林,曹大春,刘玉芬,等.中医医院积极开展中药临方炮制的思路与方法[J].光明中医,2016,31(3):431.
[40]杜若飞,冯怡,徐德生,等.湿法制粒中软材物性参数的表征方法研究[C].山西:2009全国中药创新与研究论坛,2009:85.
[41]Du Y,Zhao L J,Feng Y,et al.Compression behavior evaluation of directly compressible excipients[J].Adv Mater Res,2012,428/484:1672.
[42]高雅,洪燕龙,鲜洁晨,等.物性测试仪用于制剂软材特征物理性质的表征方法研究[J].药学学报,2012(8):1049.
[43]Gao Y,Hong Y,Xian J,et al.A protocol for the classification of wet mass in extrusion-spheronization[J].Eur J Pharm Biopharm,2013,85(3):996.
[44]L X H,Zhao L J,Ruan K P,et al.The application of factor analysis to evaluate deforming behaviors of directly compressed powders[J].Powder Technol,2013,247:47.
[45]王玲,鲜洁晨,洪燕龙,等.塑制法制备中药丸剂中丸条物理特性丸剂质量相关性研究[J].中国中药杂志,2012,37(9):1206.
[46]Wang S,Li J,Lin X,et al.Novel coprocessed excipients composed of lactose,HPMC,and PVPP for tableting and its application[J].Int J Pharm,2015,486(1/2):370.
[47]Li J,Lin X,Wu F,et al.Application of the central composite design to optimize the calcium carbonate-HPMC co-processed excipient prepared by co-spray drying[J].RSC Adv,2015,5(114):94105.
[48]Li J,Wu F,Lin X,et al.Novel application of hydroxypropyl methylcellulose to improving direct compaction properties of tablet fillers by co-spray drying[J].RSC Adv,2015,5(85):69289.
[49]Sun C C.A classification system for tableting behaviors of binary powder mixtures[J].Asian J Pharm Sci,2016,11(4):486.
[50]Li Z,Lin X,Shen L,et al.Composite particles based on particle engineering for direct compaction[J].Int J Pharm,2017,519(1/2):272.
[51]Li J,Zhao L,Lin X,et al.Co-spray drying with HPMC as a platform to improve direct compaction properties of various tablet fillers[J].AAPS Pharm Sci Tech,2017,18(8):3105.
[52]M L S,Li Z,Wu F,et al.A two-step approach for fluidized bed granulation in pharmaceutical processing:assessing different models for design and control[J].PLoS ONE,2017,12(6):e0180209.
[53]李雪,洪燕龙,鲜洁晨,等.基于转矩流变性的中药微丸润湿剂用量筛选研究[J].中国中药杂志,2017,42(17):3341.
[54]李雪,洪燕龙,杜若飞,等.挤出滚圆过程中挤出物表面粗糙度的表征方法[J].中国医药工业杂志,2017(1):63.
[55]李雪.基于挤出物表面粗糙度的中药微丸成型性假说验证研究[D].上海:上海中医药大学,2017.
[56]明良山,李哲,吴飞,等.基于表面自由能性质的物料压缩特性研究[J].药学学报,2017,52(7):1170.
[57]郑亚平.基于挤出物表面粗糙度的中药微丸成型基础研究[D].上海:上海中医药大学,2018.
[58]冯怡,洪燕龙,鲜洁晨,等.基于QbD理念的中药新药成型工艺研发模式的探讨[J].中国中药杂志,2014,39(17):3404.
[59]刘怡,冯怡,徐德生.中药制剂技术研究应关注提取物的物理性质[J].中成药,2007(10):1495.
[60]冯怡,杜若飞,洪燕龙,等.关于构建中药制剂工艺设计专家系统的思考[J].世界科学技术---中医药现代化,2013,15(1):25.
[61]姬杰玮.Fitzpatrick公司干法制粒机的动态观察与探讨[J].机电信息,2013(2):53.
[62]赵立杰,冯怡,徐德生,等.基于多元数据分析研究中药制剂原料吸湿性与其他物理特性的相关性[J].药学学报,2012,47(4):517.
[63]Michrafy A,Diarra H,Dodds J A,et al.Analysis of strain stress state in roller compaction process[J].Power Technol,2011,208(2):417.
[64]李洁,杜若飞,冯怡,等.中药浸膏粉物理性质与干法制粒工艺的相关性研究[J].中国中药杂志,2011,36(12):1606.
[65]杨秀娟,洪燕龙,阮克锋,等.基于制剂原料物理特性的止颤颗粒干法制粒处方与工艺优选[J].中国实验方剂学杂志,2013,19(4):27.
[66]李更青,吴飞,胡佳亮,等.基于制剂原料物理性质的抗甲方颗粒干法制粒工艺研究[J].中草药,2018,49(3):575.
[67]朱蕾,李姝琦,冯怡,等.物料物理性质与片剂成型性的相关性研究[J].中成药,2010,32(8):1402.
[68]杨明,伍振峰,王芳,等.中药制药实现绿色、智能制造的策略与建议[J].中国医药工业杂志,2016,47(9):1205.
[69]中国智慧制药2025”杭州宣言发布[J].天津中医药,2017,34(1):2.
[70]中国智慧制药2025”高峰论坛:发布“中国智慧制药2025”杭州宣言[J].中国中药杂志,2016,41(24):4468.
[71]杨明,伍振峰,王雅琪,等.中药制药装备技术升级的政策、现状与途径分析[J].中草药,2013,44(3):247.